Stocks › CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV·Nasdaq·United States United States·USD
$3.73
-0.04 (-1.06%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CLOVS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CLOV by members of U.S. Congress · 0 on record

No congressional trades in CLOV on record.

Whale Activity

Position changes in CLOV reported for 2026-09-30 by 261 institutional filers
Increased: 77New: 38Held: 58Decreased: 45Closed: 32No prior filing: 11
  • Increased77
  • New38
  • Held58
  • Decreased45
  • Closed32
  • No prior filing11
FilerSharesValueChange
BlackRock, Inc.36.5M$157.4Mincreased
VANGUARD CAPITAL MANAGEMENT LLC18.4M$79.2Mincreased
GEODE CAPITAL MANAGEMENT, LLC11.1M$47.9Mincreased
STATE STREET CORP10.7M$46.1Mincreased
Nuveen, LLC7.8M$33.7Mincreased
VANGUARD PORTFOLIO MANAGEMENT LLC7.6M$32.7Mincreased
CHARLES SCHWAB INVESTMENT MANAGEMENT INC5.9M$25.3Mincreased
RENAISSANCE TECHNOLOGIES LLC4.6M$19.6Mincreased
D. E. Shaw & Co., Inc.4.4M$18.9Mincreased
NORTHERN TRUST CORP3.8M$16.3Mincreased
DIMENSIONAL FUND ADVISORS LP3.4M$14.5Mincreased
VANGUARD FIDUCIARY TRUST CO3.1M$13.3Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CLOV insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -327.5K2025 Q12025 Q2: -20.4K2025 Q22025 Q3: 230.1K2025 Q32025 Q4: -53.8K2025 Q42026 Q1: -187.5K2026 Q12026 Q2: -418.4K2026 Q22026 Q3: -940.6K2026 Q32026 Q4: -498.3K2026 Q4

Recent Insider Transactions

357 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
THORNTON JOSEPH CLAYChief Financial Officer Sale −22.1K $4.97 $110K Nov 16, 2026 Form 4 ↗
Soares KarenChief Legal Officer Sale −19.3K $4.66 $90K Oct 20, 2026 Form 4 ↗
Reynoso Jamie L.CEO, Medicare Advantage Sale −4,066 $4.41 $18K Oct 19, 2026 Form 4 ↗
Toy AndrewChief Executive Officer · Director Sale −62.2K $4.68 $291K Oct 15, 2026 Form 4 ↗
Soares KarenChief Legal Officer Sale −14.7K $4.68 $69K Oct 15, 2026 Form 4 ↗
THORNTON JOSEPH CLAYInterim CFO Sale −4,591 $4.68 $21K Oct 15, 2026 Form 4 ↗
Wai ConradCEO, Counterpart Health Sale −23.6K $4.68 $111K Oct 15, 2026 Form 4 ↗
Reynoso Jamie L.CEO, Medicare Advantage Sale −18.3K $4.68 $86K Oct 15, 2026 Form 4 ↗
Reynoso Jamie L.CEO, Medicare Advantage Sale −2,006 $4.63 $9K Oct 7, 2026 Form 4 ↗
Reynoso Jamie L.CEO, Medicare Advantage Sale −8,750 $4.42 $39K Oct 5, 2026 Form 4 ↗
Toy AndrewChief Executive Officer · Director Sale −318.8K $4.19 $1.3M Oct 1, 2026 Form 4 ↗
Reynoso Jamie L.CEO, Medicare Advantage Sale −1,921 $4.56 $9K Sep 17, 2026 Form 4 ↗
OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER Sale −3,170 $4.64 $15K Sep 16, 2026 Form 4 ↗
Wai ConradCEO, Counterpart Health Sale −300.0K $4.72 $1.4M Sep 15, 2026 Form 4 ↗
Soares KarenChief Legal Officer Sale −6,846 $4.78 $33K Sep 15, 2026 Form 4 ↗
Reynoso Jamie L.CEO, Medicare Advantage Sale −9,273 $4.78 $44K Sep 15, 2026 Form 4 ↗
OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER Sale −20.0K $5.16 $103K Sep 14, 2026 Form 4 ↗
THORNTON JOSEPH CLAYInterim CFO Sale −17.8K $4.39 $78K Aug 17, 2026 Form 4 ↗
Soares KarenChief Legal Officer Grant / award +108.7K $0.00 $0 Aug 12, 2026 Form 4 ↗
THORNTON JOSEPH CLAYInterim CFO Grant / award +54.3K $0.00 $0 Aug 12, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CLOV · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
13.0M$68.0M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
10.8M$56.6M0.07%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
4.6M$24.3M0.02%Jun 30, 2026
iShares Russell 2000 Growth ETF
iShares Trust
3.9M$20.4M0.13%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
4.6M$19.2M0.06%Jul 31, 2026
VANGUARD RUSSELL 2000 INDEX FUND
VANGUARD SCOTTSDALE FUNDS
2.4M$10.0M0.06%Aug 31, 2026
College Retirement Equities Fund - Total Global Stock Account
College Retirement Equities Fund
1.8M$9.7M0.01%Jun 30, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
2.0M$8.2M0.02%Aug 31, 2026
Schwab U.S. Small-Cap ETF
SCHWAB STRATEGIC TRUST
1.9M$8.0M0.04%Aug 31, 2026
Nuveen Quant Small Cap Equity Fund
TIAA-CREF Funds
1.8M$7.4M0.18%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list CLOV's shares (CUSIP 18914F103), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming CLOVER HEALTH INVESTMENTS, CORP. /DE as client

No lobbying filings found naming CLOVER HEALTH INVESTMENTS, CORP. /DE as the client.

Government Contracts

Federal awards to CLOVER HEALTH INVESTMENTS, CORP. /DE · USAspending

No federal contract awards found for CLOVER HEALTH INVESTMENTS, CORP. /DE.

U.S. Patents

Recent USPTO applications naming CLOVER HEALTH INVESTMENTS, CORP. /DE

No USPTO patent applications found for CLOVER HEALTH INVESTMENTS, CORP. /DE.

Annual Financials

From CLOV's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$1.92B$1.37B$1.26B$1.10B$1.47B
Operating income-$85.5M-$45.7M-$205.3M-$286.7M-$637.0M
Net income-$85.5M-$43.0M-$213.4M-$339.6M-$587.8M
Diluted EPSn/an/a-$0.44-$0.71-$1.42
Operating cash flow-$66.9M$34.8M-$144.7M-$203.9M-$282.3M
Cash and equivalents$78.3M$194.5M$122.9M$103.8M$300.0M
Total assets$541.0M$580.7M$570.7M$808.6M$950.8M
Total liabilities$232.3M$239.6M$284.3M$451.7M$410.8M
Shareholders' equityn/an/an/a$347.7M$535.4M

As CLOVER HEALTH INVESTMENTS, CORP. /DE tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 27, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in CLOV's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 9.01Reg FD disclosureNov 16, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 5.02, 9.01Results of operations · Officer / director changeNov 4, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureOct 9, 2026
    EDGAR ↗
  • 8-K/A · Items 5.02, 9.01Officer / director changeSep 25, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 9.01Officer / director changeSep 24, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureAug 20, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJul 17, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJun 18, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeJun 16, 2026
    EDGAR ↗

About CLOVER HEALTH INVESTMENTS, CORP. /DE

From SEC EDGAR company records
Industry (SIC 6324)Hospital & Medical Service Plans
SectorFinancials
HeadquartersJERSEY CITY, NJ
IncorporatedDE
Former namesSocial Capital Hedosophia Holdings Corp. III